The pharmacokinetics of intravenous ondansetron in patients with hepatic impairment.
about
Serotonin receptor antagonists for highly emetogenic chemotherapy in adultsSerotonin receptor antagonists for highly emetogenic chemotherapy in adultsComparison of clinical efficacy of serotonin receptor antagonists in highly emetogenic chemotherapyA clinical perspective on mucoadhesive buccal drug delivery systemsThe pharmacokinetics of ondansetron after intravenous injection in healthy volunteers phenotyped as poor or extensive metabolisers of debrisoquinePharmacokinetics of dolasetron after oral and intravenous administration of dolasetron mesylate in healthy volunteers and patients with hepatic dysfunction.Cardiac safety concerns for ondansetron, an antiemetic commonly used for nausea linked to cancer treatment and following anaesthesia.Clinical pharmacokinetics of ondansetron. A review.
P2860
Q24202033-8C7656E8-EF8D-4BB8-8BC0-FD33F2EBDCAFQ24240511-6B94666A-6C5F-44EC-AD71-1BA275F28E7AQ24244745-E70E8E4E-91E9-4CBA-A4C8-C8855D3C5D67Q27023412-C7BD29AF-B204-4509-AA95-7793953E6838Q34346070-D9D7FEE5-387B-4CA1-BBDA-5DFB7D7A4B3CQ36895764-1BB768AC-BAFC-4CFE-97B0-55768E9A499DQ38098277-B4BC15A4-4018-4898-8F4A-8B98AD9556A0Q41184687-FE50ABFF-2762-4205-9C10-E8BF04EE6E8B
P2860
The pharmacokinetics of intravenous ondansetron in patients with hepatic impairment.
description
1993 nî lūn-bûn
@nan
1993 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
The pharmacokinetics of intravenous ondansetron in patients with hepatic impairment.
@ast
The pharmacokinetics of intravenous ondansetron in patients with hepatic impairment.
@en
The pharmacokinetics of intravenous ondansetron in patients with hepatic impairment.
@nl
type
label
The pharmacokinetics of intravenous ondansetron in patients with hepatic impairment.
@ast
The pharmacokinetics of intravenous ondansetron in patients with hepatic impairment.
@en
The pharmacokinetics of intravenous ondansetron in patients with hepatic impairment.
@nl
prefLabel
The pharmacokinetics of intravenous ondansetron in patients with hepatic impairment.
@ast
The pharmacokinetics of intravenous ondansetron in patients with hepatic impairment.
@en
The pharmacokinetics of intravenous ondansetron in patients with hepatic impairment.
@nl
P2093
P1476
The pharmacokinetics of intravenous ondansetron in patients with hepatic impairment.
@en
P2093
P304
P356
10.1111/J.1365-2125.1993.TB04164.X
P407
P577
1993-04-01T00:00:00Z